TriSalus wins FDA 510(k) clearance for TriNav Advance liver embolization device
T
TLSI• FDA clearance expands TriNav Advance device portfolio
- TriSalus Life Sciences received FDA 510(k) clearance for TriNav Advance, expanding its Pressure-Enabled Drug Delivery device portfolio.
The device broadens access to smaller distal vessels, supporting a wider range of embolization procedures beyond liver-directed therapy.A limited market release is planned over the coming weeks.TriSalus wins FDA 510(k) clearance for TriNav Advance liver embolization device - TLSI News | Rallies